Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study

J Clin Epidemiol. 2014 Nov;67(11):1222-8. doi: 10.1016/j.jclinepi.2014.05.006. Epub 2014 Jun 23.

Abstract

Objectives: The American College of Chest Physicians Antithrombotic Guidelines ninth iteration placed restrictions on panelists with recommendations on which they disclosed a primary conflict of interest (COI). We aimed to describe panelists' financial and intellectual COI and evaluate to what extent, beyond assessing financial COI, assessing intellectual COI affected COI management.

Study design and setting: We classified financial and intellectual COI into primary (causes voting restriction) and secondary (no restrictions). We analyzed disclosures respectively with panelists and recommendations as units of analysis.

Results: One hundred two panelists made 4,030 disclosures for 431 recommendations. The median number (and range) of panelists per recommendation who disclosed the various categories of COI was 0 (0-5) for primary financial COI, 0 (0-4) for secondary financial COI, 0 (0-7) for primary intellectual COI, and 1 (0-6) for secondary intellectual COI. Of the 431 recommendations, 63 (15%) had at least one panelist with a primary intellectual COI but no primary financial COI.

Conclusion: COI had a relatively low prevalence and a skewed distribution, many panelists with none and some with many disclosures. A substantial number of disclosures should have resulted in restrictions based on intellectual COI in the absence of financial COI.

Keywords: Clinical practice guideline; Consensus development; Financial conflicts of interest; Guideline panel; Intellectual conflicts of interest; Thrombosis.

MeSH terms

  • Conflict of Interest*
  • Disclosure / ethics*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Practice Guidelines as Topic / standards*
  • Thrombosis / therapy*

Substances

  • Fibrinolytic Agents